Johns Hopkins will launch the world's first institute devoted to bladder cancer.
Johns Hopkins University in Baltimore on October 15 will launch the world’s first institute devoted to bladder cancer.
The Johns Hopkins Greenberg Bladder Cancer Institute, established with a co-investment by the university and Erwin and Stephanie Greenberg, is expected to be staffed by bladder cancer specialists, urologists, medical oncologists, radiation oncologists, pathologists, and researchers.
The institute “will serve as the hub of an institutional and international community of researchers who share a commitment to advancing the scientific understanding of bladder cancer and improving its treatment,” according to a press release. William B. Isaacs, MD, professor of urology and oncology at Johns Hopkins and an authority in molecular genetics of prostate cancer and other urologic diseases, will serve as the institute’s interim director.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.